SCHEMBL1819937

SCHEMBL1819937

N#Cc1cccc(S(=O)(=O)Nc2ccc3c(c2)c(=O)[nH]n3Cc2ccc(F)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.52
BRD1 O95696 2/20 0.49
BRPF1 P55201 2/20 0.49
MAP2K4 P45985 1/20 0.44
PGR P06401 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
HSPD1 P10809 1/20 0.42
PTPN2 P17706 1/20 0.42
PTPN1 P18031 1/20 0.42
PTPN5 P54829 1/20 0.42
HSPE1 P61604 1/20 0.42
TRIM24 O15164 1/20 0.41
MAPT P10636 1/20 0.41
ACLY P53396 1/20 0.41
HTR6 P50406 1/20 0.40
CCR9 P51686 1/20 0.40
ATIC P31939 1/20 0.39
SGK1 O00141 1/20 0.39
CCR1 P32246 1/20 0.39
CCR2 P41597 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3904637 0.87 BRD4 (0.50) BRD4MAP2K4PGRMAPTSERPINE1
SCHEMBL5610031 0.85 BRD4 (0.54) BRD4BRD1BRPF1MAP2K4PGR
SCHEMBL3906469 0.82 BRPF1 (0.54) BRD4BRD1BRPF1PGRRXFP1
SCHEMBL3909056 0.82 BRD4 (0.40) BRD4MAP2K4PGRSERPINE1ALDH1A1
SCHEMBL1811639 0.81 PTGDR2 (0.48) MAPTALDH1A1
SCHEMBL1810977 0.81 ACLY (0.53) BRD4BRD1BRPF1PGRRXFP1
SCHEMBL3917126 0.80 BRD4 (0.49) BRD4PGRMAPTHTR6SERPINE1
SCHEMBL1843321 0.79 FFAR4 (0.43) HSPD1PTPN2PTPN1PTPN5HSPE1
SCHEMBL4536214 0.79 NR1I2 (0.52) BRD4PGRPTPN2PTPN1PTPN5
SCHEMBL1808705 0.78 PKM (0.51) MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4682207-B2 2011-05-11 JP claimed
US-7528158-B2 Indazolone derivatives useful as 11b-HSD1 inhibitors HOFFMANN-LA ROCHE INC. (US) 2009-05-05 US claimed
EP-1797042-B1 INDOZOLONE DERIVATIVES AS 11B-HSD1 INHIBITORS HOFFMANN LA ROCHE (CH) 2009-01-07 EP claimed
EP-1797042-A1 INDOZOLONE DERIVATIVES AS 11B-HSD1 INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2007-06-20 EP claimed
WO-2006034804-A1 INDOZOLONE DERIVATIVES AS 11B-HSD1 INHIBITORS F.HOFFMANN-LA ROCHE AG (CH) 2006-04-06 WO claimed
US-20060069269-A1 Novel indazolone derivatives useful as 11b-HSD1 inhibitors F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2006-03-30 US claimed
US-7528158-B2 Indazolone derivatives useful as 11b-HSD1 inhibitors HOFFMANN-LA ROCHE INC. (US) 2009-05-05 US disclosed
EP-1797042-B1 INDOZOLONE DERIVATIVES AS 11B-HSD1 INHIBITORS HOFFMANN LA ROCHE (CH) 2009-01-07 EP disclosed
US-20060069269-A1 Novel indazolone derivatives useful as 11b-HSD1 inhibitors F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2006-03-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060069269-A1 Novel indazolone derivatives useful as 11b-HSD1 inhibitors HSD17B1, HSD11B1, HSD17B7 BRD4 2606/4885BRD1 1486/4885BRPF1 4076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.